优势价格
快速发货
品质保证
技术支持
400-920-2911 sales@csnpharm.cn
| 货号 | 产品名 | CAS号 | 信息 |
|---|---|---|---|
| CSN_mab1012 | Bevacizumab | 216974-75-3 | Bevacizumab is a recombinant humanized monoclonal immunoglobulin (Ig) G1 antibody that binds to all isoforms and bioactive proteolytic fragments of human vascular endothelial growth factor-A (VEGF), which is essential for both normal and tumor angiogenesis. It is approved for the treatment of patients with metastatic colorectal cancer, advanced nonsquamous non-small cell lung cancer, metastatic renal cell carcinoma, recurrent glioblastoma, advanced cervical cancer, and platinum-resistant ovarian cancer. |
| CSN_mab1013 | Cetuximab | 205923-56-4 | |
| CSN_mab1011 | Nivolumab (anti-PD-1) | 946414-94-4 | |
| CSN_mab1002 | Canakinumab | 914613-48-2 | |
| CSN_mab1006 | Pertuzumab (PBS) | 380610-27-5 | |
| CSN_mab1010 | Rituximab (anti-CD20) | 174722-31-7 | |
| CSN_mab1004 | Trastuzumab | 180288-69-1 | |
| CSN_mab1005 | Pembrolizumab | 1374853-91-4 | |
| CSN_mab1001 | Ipilimumab | 477202-00-9 | |
| CSN_mab1018 | Dupilumab | 1190264-60-8 | |
| CSN_mab1023 | Durvalumab | 1428935-60-7 | |
| CSN_mab1024 | Guselkumab | 1350289-85-8 | |
| CSN_mab1019 | Secukinumab | 1229022-83-6 | |
| CSN_mab1025 | Vedolizumab (anti-α4β7-integrin) | 943609-66-3 | |
| CSN_mab1028 | Atezolizumab | 1380723-44-3 | |
| CSN43453 | Avelumab | 1537032-82-8 | |
| CSN73199 | Gemtuzumab ozogamicin | 220578-59-6 | |
| CSN73088 | Aducanumab | 1384260-65-4 | |
| CSN73256 | Varlilumab | 1393344-72-3 | |
| CSN73257 | Oleclumab | 1803176-05-7 | |
| CSN73262 | Magrolimab | 2169232-81-7 | |
| CSN73264 | Selicrelumab | 1622140-49-1 | |
| CSN73267 | Onvatilimab | 1969313-51-6 | |
| CSN73315 | Belantamab | 2061894-48-0 | |
| CSN75614 | Ofatumumab | 679818-59-8 | |
| CSN79937 | Zolbetuximab | 1496553-00-4 | |
| CSN80037 | Cibisatamab | 1855925-27-7 | |
| CSN79679 | Girentuximab | 916138-87-9 | |
| CSN80168 | Fremanezumab | 1655501-53-3 | |
| CSN79756 | Galcanezumab | 1578199-75-3 | |
| CSN80214 | Dacetuzumab | 880486-59-9 | |
| CSN79788 | Erenumab | 1582205-90-0 | |
| CSN79832 | Atibuclimab | 2417175-94-9 | |
| CSN80435 | Blinatumomab | 853426-35-4 | |
| CSN80043 | Batoclimab | 2187430-05-1 | |
| CSN80066 | Ibalizumab | 680188-33-4 | |
| CSN80514 | Isatuximab (anti-CD38) | 1461640-62-9 | |
| CSN80113 | Gantenerumab | 1043556-46-2 | |
| CSN80543 | Eptinezumab | 1644539-04-7 | |
| CSN81505 | Tusamitamab | 2349294-95-5 | |
| CSN90050 | Mosunetuzumab | 1905409-39-3 | |
| CSN89844 | Monalizumab | 1228763-95-8 | |
| CSN90064 | Sutimlimab | 2049079-64-1 | |
| CSN91653 | Muromonab | 140608-64-6 | |
| CSN91659 | Farletuzumab | 896723-44-7 | |
| CSN91714 | Zalutumumab | 667901-13-5 |
